Literature DB >> 17301616

Mechanisms of action and efficacy of argon laser trabeculoplasty and selective laser trabeculoplasty.

Joshua D Stein1, Pratap Challa.   

Abstract

PURPOSE OF REVIEW: Since the 1980s, laser trabeculoplasty has served as an effective way to lower intraocular pressure in patients with primary or secondary open angle glaucomas, both as an initial therapy or in conjunction with hypotensive medications. This manuscript will describe the proposed mechanisms of action of argon laser trabeculoplasty and selective laser trabeculoplasty, as well as review current studies of the therapeutic effect of these interventions. RECENT
FINDINGS: The exact mechanisms by which argon laser and selective laser trabeculoplasty lower intraocular pressure are not known. There are several theories, however, and we discuss the three most common ones: the mechanical theory, the cellular (biologic) theory, and the cell division theory. Since both lasers are applied to the same tissue and produce similar results, they most likely produce their effects in comparable ways. We also describe the results of several studies comparing these devices. Most show them to be equally effective at lowering intraocular pressure; however, there are a few circumstances when selective laser trabeculoplasty may be a better option than argon laser trabeculoplasty.
SUMMARY: Argon laser and selective laser trabeculoplasty are safe and effective procedures for lowering intraocular pressure. The results of ongoing clinical trials will help further define their role in the management of patients with open angle glaucoma.

Entities:  

Mesh:

Year:  2007        PMID: 17301616     DOI: 10.1097/ICU.0b013e328086aebf

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  31 in total

Review 1.  [Excimer laser trabeculotomy: minimally invasive glaucoma surgery].

Authors:  S Herdener; M Pache
Journal:  Ophthalmologe       Date:  2007-08       Impact factor: 1.059

2.  [Available laser systems and mechanism of action in laser trabeculoplasty].

Authors:  G R K Kuerzinger; S Eckert
Journal:  Ophthalmologe       Date:  2010-01       Impact factor: 1.059

3.  Impact of laser pulse duration on the reduction of intraocular pressure during selective laser trabeculoplasty.

Authors:  Spela Stunf Pukl; Brigita Drnovšek-Olup
Journal:  Int Ophthalmol       Date:  2016-12-31       Impact factor: 2.031

4.  SALT Trial: Steroids after Laser Trabeculoplasty: Impact of Short-Term Anti-inflammatory Treatment on Selective Laser Trabeculoplasty Efficacy.

Authors:  Sylvia L Groth; Eiyass Albeiruti; Mariana Nunez; Roman Fajardo; Lucie Sharpsten; Nils Loewen; Joel S Schuman; Jeffrey L Goldberg
Journal:  Ophthalmology       Date:  2019-06-06       Impact factor: 12.079

Review 5.  CRISPR-Cas9 genome engineering: Treating inherited retinal degeneration.

Authors:  Erin R Burnight; Joseph C Giacalone; Jessica A Cooke; Jessica R Thompson; Laura R Bohrer; Kathleen R Chirco; Arlene V Drack; John H Fingert; Kristan S Worthington; Luke A Wiley; Robert F Mullins; Edwin M Stone; Budd A Tucker
Journal:  Prog Retin Eye Res       Date:  2018-03-22       Impact factor: 21.198

6.  Selective laser trabeculoplasty in patients with pseudoexfoliative glaucoma vs primary open angle glaucoma: a one-year comparative study.

Authors:  Arezoo Miraftabi; Naveed Nilforushan; Nariman Nassiri; Kouros Nouri-Mahdavi
Journal:  Int J Ophthalmol       Date:  2016-03-18       Impact factor: 1.779

7.  Efficacy of selective laser trabeculoplasty in primary angle closure disease.

Authors:  Srishti Raj; Basavraj Tigari; T T Faisal; Natasha Gautam; Sushmita Kaushik; Parul Ichhpujani; Surinder S Pandav; Jagat Ram
Journal:  Eye (Lond)       Date:  2018-07-09       Impact factor: 3.775

8.  Cost-effectiveness of medications compared with laser trabeculoplasty in patients with newly diagnosed open-angle glaucoma.

Authors:  Joshua D Stein; David D Kim; Will W Peck; Steven M Giannetti; David W Hutton
Journal:  Arch Ophthalmol       Date:  2012-02-13

9.  Bovine posterior limbus: an evaluation of an alternative source for corneal endothelial and trabecular meshwork stem/progenitor cells.

Authors:  Wing Yan Yu; Ian Grierson; Carl Sheridan; Amy Cheuk-Yin Lo; David Sai-Hung Wong
Journal:  Stem Cells Dev       Date:  2014-12-22       Impact factor: 3.272

Review 10.  Recent Advances in the Surgical Management of Glaucoma in Exfoliation Syndrome.

Authors:  Mohamed S Sayed; Richard K Lee
Journal:  J Glaucoma       Date:  2018-07       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.